About Continuus Pharma
Continuus Pharma is a Healthcare company based in Woburn (United States) founded in 2012. MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development. Continuus Pharma has raised $7.73 million across 7 funding rounds from investors including Industria Macchine Automatiche, Mark Bamforth and National Science Foundation. The company has 47 employees. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its legal entity is CONTINUUS PHARMACEUTICALS. Its competitors include Asymchem and Pharmaceutics International.
Company details
Formed as a spinout company of the 65M collaboration between MIT and Novartis, Continuus Pharma offers one stop solutions for the development and manufacturing of continuous manufacturing solutions by removing the walls between API and FDF manufacturing. Their proprietary Integrated Continuous Manufacturing (ICM) technology for small molecule pharmaceuticals integrates the entire API and FDF manufacturing process into a continuous and seamless process and offers capabilities for on-demand manufacturing of pharmaceuticals and thus significant advantages w.r.t lead time, costs and quality. Apart from integrated solutions, they also offer targeted solutions for a wide range of unit operations such as a continuous reactor to handle solids in flow, membrane separator by-pass, heterogeneous crystallization, integrated nucleator and tubular crystallizers, continuous filtration, continuous dryer, extrusionforming and thin filmelectrospinning.
- Headquarters Woburn, United States
- Employees 47
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website continuuspharma.com
- Social LinkedIn
- Legal Name Continuus Pharmaceuticals
- Total Equity Funding$7.73M (USD)
in 7 rounds
- Latest Funding Round$5M (USD), Series B
Aug 2019
- InvestorsIndustria Macchine Automatiche
& 2 more
- Employee Count47
Funding Insights of Continuus Pharma
Continuus Pharma has successfully raised a total of $7.73M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $5 million completed in August 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.73M
- Total Rounds 7
- Last Round Series B — $5M
- First Round $265,000
(May 2013)
- Investors Count 3
All 7 funding rounds of Continuus Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2019 | $5M | Series B | – | Mark Bamforth | |
| Mar 2016 | $1.26M | Grant | – | – | |
| Feb 2016 | $1.26M | Grant | – | – | |
| Jan 2015 | $150,000 | Grant | – | – | |
| Dec 2014 | $150,000 | Grant | – | – | |
| Jun 2014 | $2.46M | Series A | – | Industria Macchine Automatiche | – |
| May 2013 | $265,000 | Seed | – | – | – |
3 investors in total: 2 institutional and 1 angel.
Investors in Continuus Pharma
Continuus Pharma has secured backing from 3 investors, including angel and institutional investors. Prominent investors backing the company include Industria Macchine Automatiche, Mark Bamforth and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Automated packaging machinery is manufactured for multiple industries. | 1961 | ima.it | Bologna, Italy | |
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
MB Mark Bamforth | unknown_61ed0c4f7fe144efa |
Investor details for Continuus Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Continuus Pharma
22 people are tracked at Continuus Pharma (9 in leadership, 10 in board & advisors, 3 in team); the tracked headcount is 47.
| Name | Role | Group |
|---|---|---|
Randall Goyette | DIRECTOR, ENVIRONMENTAL HEALTH & SAFETY | Leadership |
Bayan Takizawa | Co-Founder & Chief Business Officer | Leadership |
Salvatore Mascia | Founder & CEO | Leadership |
Keith Barbato | Principal Scientist And Director Of Business Development | Leadership |
Jason Whipp | Senior Director, Head of IT | Leadership |
Youhua Li | Head Of Analytical Development，associate Director | Leadership |
Dean Hopkins | Senior Vice President, Head of Commercial | Leadership |
Elizabeth (Liz) Pool, SHRM-SCP | Head of Human Resources | Leadership |
Stephen Born | Senior Director, Head Of Scientific Affairs | Leadership |
Bernhardt L. Trout | Director | Board & advisors |
Timothy F. Jamison | Advisor | Board & advisors |
Jonathan Fleming | Director | Board & advisors |
Mark R. Bamforth | Director | Board & advisors |
Steve Favaloro | Advisor | Board & advisors |
Andrea Semprini Cesari | Director | Board & advisors |
Charles L. Cooney | Advisor | Board & advisors |
Allan S. Myerson | Advisor | Board & advisors |
Moheb M. Nasr | Advisor | Board & advisors |
Tom Van Laar | Advisor | Board & advisors |
Priya Bharate | Analytical Scientist I | Team |
2 more people are available in the full profile.
Complete people profiles for Continuus Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Continuus Pharma
3 dated milestones of Continuus Pharma across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Continuus Pharma is founded.
- Funding First funding round of $265K.
- Funding Latest funding round, Series B, of $5.0M.
Competitors of Continuus Pharma
Continuus Pharma has 2 listed competitors in our database. They include Asymchem and Pharmaceutics International.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| asymchem.com | 1995 | Morrisville, United States | 48 | APIs and peptides are developed and manufactured by Asymchem. | ||
| pharm-int.com | 1994 | Hunt Valley, United States | 248 | Pharmaceutical dosage forms are manufactured by this CDMO. |
Detailed competitors of Continuus Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Continuus Pharma
The website of Continuus Pharma (continuuspharma.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▼ 29.9% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Continuus Pharma (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Continuus Pharma
Complete news archive for Continuus Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Continuus Pharma
Continuus Pharma was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Continuus Pharma is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Continuus Pharma is a funded company, having raised a total of $7.73M across 7 funding rounds to date. The company's 1st funding round was a Seed of $265K, raised on May 2013.
Continuus Pharma has 47 employees.
Formed as a spinout company of the 65M collaboration between MIT and Novartis, Continuus Pharma offers one stop solutions for the development and manufacturing of continuous manufacturing solutions by removing the walls between API and FDF manufacturing. Their proprietary Integrated Continuous Manufacturing (ICM) technology for small molecule pharmaceuticals integrates the entire API and FDF manufacturing process into a continuous and seamless process and offers capabilities for on-demand manufacturing of pharmaceuticals and thus significant advantages w.r.t lead time, costs and quality. Apart from integrated solutions, they also offer targeted solutions for a wide range of unit operations such as a continuous reactor to handle solids in flow, membrane separator by-pass, heterogeneous crystallization, integrated nucleator and tubular crystallizers, continuous filtration, continuous dryer, extrusionforming and thin filmelectrospinning.
Continuus Pharma's top competitors include Pharmaceutics International and Asymchem.
Continuus Pharma has 3 investors. Key investors include Industria Macchine Automatiche, Mark Bamforth, and National Science Foundation.
Continuus Pharma operates through Continuus Pharmaceuticals.